[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].

[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].

OBJECTIVE: To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals. METHODS: Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Zhang, D, Ge, L, Li, J, Li, X, Feng, F, Chen, Y, Chen, Z, Martin, L, Jane, A, Chen, F, Jiang, L
Formato:	Journal article
Idioma:	Chinese
Publicado em:	2011

Registos relacionados

[A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China.]
Por: Jiang, L, et al.
Publicado em: (2010)

Underuse of statins in patients with atherosclerotic ischemic stroke in China.
Por: Li, X, et al.
Publicado em: (2012)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
Por: Cheng Yang, et al.
Publicado em: (2023-12-01)

The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy
Por: Maharani F. Iskandar, et al.
Publicado em: (2018-04-01)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
Por: Yu-Cheng Kao, et al.
Publicado em: (2021-03-01)

Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
Por: Lingmin Zhao, et al.
Publicado em: (2023-12-01)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
Por: Vignesh Chidambaram, et al.
Publicado em: (2021-07-01)

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
Por: Yi Guo, et al.
Publicado em: (2020-12-01)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
Por: Yinchu Cheng, et al.
Publicado em: (2022-10-01)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
Por: Michael P. Dorsch, et al.
Publicado em: (2019-11-01)

Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular Disease
Por: Sha Li, et al.
Publicado em: (2022-04-01)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
Por: Xue-Li Yang, et al.
Publicado em: (2016-06-01)

The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients
Por: Wang X, et al.
Publicado em: (2023-07-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
Por: Ashish Sarraju, et al.
Publicado em: (2024-03-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
Por: Teimur Kayani, et al.
Publicado em: (2024-03-01)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
Por: Myunhee Lee, et al.
Publicado em: (2023-07-01)

Controlling the thickness of the atherosclerotic plaque by statin medication.
Por: Dorota Formanowicz, et al.
Publicado em: (2020-01-01)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
Por: Yi-Heng Li, et al.
Publicado em: (2020-12-01)

Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older
Por: Wang Z, et al.
Publicado em: (2024-03-01)

Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese
Por: Wang Y, et al.
Publicado em: (2022-08-01)

Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
Por: Armitage, J, et al.
Publicado em: (2004)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
Por: Shu-ting Chen, et al.
Publicado em: (2019-03-01)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?
Por: Canoy, D
Publicado em: (2014)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - Is the new guideline based on best evidence?
Por: Canoy, D
Publicado em: (2014)

Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
Por: Jianjun Li
Publicado em: (2023-03-01)

Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era
Por: Robert S. Rosenson, et al.
Publicado em: (2020-01-01)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
Por: Fahmi Y Al-Ashwal, et al.
Publicado em: (2022-01-01)

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study.
Por: Myunhee Lee, et al.
Publicado em: (2023-01-01)

Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
Por: Setia S, et al.
Publicado em: (2015-06-01)

Residential greenness and atherosclerotic cardiovascular disease risk in a rural Chinese adult population
Por: Xiaokang Dong, et al.
Publicado em: (2021-10-01)

Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study.
Por: Joseph C Engeda, et al.
Publicado em: (2020-08-01)

Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Por: Gao F, et al.
Publicado em: (2023-03-01)

Cardiovascular magnetic resonance in carotid atherosclerotic disease
Por: Chen Huijun, et al.
Publicado em: (2009-12-01)

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
Por: David C Boettiger, et al.
Publicado em: (2021-01-01)

Study on the Efficacy Differences of Moderate-dose Statin Therapy in Patients with Atherosclerotic Cardiovascular Disease among Different Ethnic Groups
Por: LUO Sifu, JIN Menglong, SUBINUER· Jureti, LIU Ziyang, FU Zhenyan
Publicado em: (2024-12-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
Por: Michael M. Hammond, et al.
Publicado em: (2023-04-01)

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
Por: Alexander R. Zheutlin, et al.
Publicado em: (2023-03-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
Por: In Sun Ryou, et al.
Publicado em: (2022-11-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
Por: Miao Wang, et al.
Publicado em: (2020-06-01)

Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease
Por: Ashish Sarraju, et al.
Publicado em: (2022-07-01)